Recombinant IIV6-118L is a genetically engineered protein derived from the Invertebrate iridescent virus 6 (IIV6), a member of the Iridoviridae family. It encodes a 515-amino-acid full-length protein (positions 2–515) with a predicted N-terminal myristoylation site and three transmembrane domains . The recombinant version is typically expressed in E. coli with an N-terminal His tag for purification and stability .
Envelope Protein Role: IIV6-118L is an essential viral envelope protein critical for initiating replication. Deletion or RNAi-mediated silencing reduces virus titer by 99% .
Membrane Anchoring: Myristoylation facilitates membrane association, a hallmark of viral envelope proteins .
Neutralization Capacity: Antibodies targeting IIV6-118L effectively neutralize viral infection, confirming its role in host-cell entry .
Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement for customized preparation.
Note: All proteins are shipped with standard blue ice packs unless dry ice shipping is requested in advance. Additional fees apply for dry ice shipping.
The tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
KEGG: vg:1733161
IIV6-118L is a viral envelope protein encoded by the 118L ORF of Invertebrate iridescent virus 6. It is a 515 amino acid protein with three predicted transmembrane domains and several N-glycosylation/N-myristoylation sites . Research has demonstrated that 118L is essential for virus replication, as attempts to isolate mutant viruses with the 118L gene deletion have been unsuccessful . The protein plays a critical role in the initiation of viral replication, and experimental evidence shows that when the 118L gene is silenced using dsRNA, there is a 99% reduction in virus titer .
118L serves as a key structural component within the viral envelope and appears to be required for virus entry or the earliest stages of viral replication. While the exact mechanism remains under investigation, the protein's membrane-associated properties suggest it likely mediates host-cell recognition, attachment, or membrane fusion processes required for viral entry .
IIV6-118L is characterized by several key structural features:
The presence of transmembrane domains indicates 118L is integrated into the viral membrane, while myristoylation sites suggest membrane anchoring functions. The high degree of conservation across the Iridoviridae family points to the fundamental importance of this protein for the viral life cycle . Structural prediction algorithms suggest the N-myristoylation likely contributes to membrane association and possibly interaction with host cell receptors.
Recombinant expression of IIV6-118L can be accomplished through several approaches:
Bacterial expression systems: E. coli-based expression systems have been successfully used to produce recombinant His-tagged IIV6-118L protein, as evident from commercially available recombinant products . This approach typically uses specialized vectors optimized for membrane protein expression, though challenges with proper folding may occur.
Baculovirus expression system: 118L-specific antibodies have been successfully produced against the 118L protein expressed in the baculovirus vector system . This eukaryotic expression system is particularly valuable for producing properly folded proteins with post-translational modifications.
Mammalian cell expression: Though not explicitly mentioned in the search results, standard protocols for expressing viral membrane proteins would apply.
When expressing membrane proteins like 118L, consideration must be given to maintaining the protein's native conformation, particularly given its transmembrane domains. Expression protocols often require optimization of detergent conditions for extraction and purification to maintain protein structure and functionality.
Several methodological approaches have proven successful in studying IIV6-118L function:
Gene silencing via RNA interference: Researchers have successfully targeted the 118L gene using dsRNA, resulting in a 99% reduction in virus titer . This method involves:
Design and synthesis of dsRNA targeting specific regions of the 118L gene
Transfection of dsRNA into insect cells followed by viral infection
Measurement of viral replication through plaque assays or viral protein quantification
Gene deletion/replacement strategies: Homologous recombination methods have been attempted to replace the 118L ORF with a green fluorescent protein (gfp) gene . While mutants could be identified by fluorescence microscopy, they could not be propagated separately from wild-type virus, supporting the essential nature of 118L .
Neutralization assays: 118L-specific antibodies produced against recombinant 118L protein expressed in baculovirus systems have been shown to neutralize IIV6 infection . This approach indicates direct blocking of the protein's function in viral entry or replication.
Protein-protein interaction studies: Yeast two-hybrid systems have been used to demonstrate that 118L interacts with the 415R protein, which appears to function as a matrix protein bridging the capsid (274L) and envelope proteins .
To investigate IIV6-118L's role in viral entry and replication, researchers can employ these methodological approaches:
Time course infection studies: Monitor 118L expression at different time points during infection using quantitative RT-PCR and Western blot analysis to determine when the protein is expressed during the viral life cycle.
Viral attachment assays: Compare the ability of wild-type virus versus 118L-silenced virus (via dsRNA treatment) to attach to host cells, using labeled virions or qPCR to quantify attached viral particles.
Membrane fusion assays: Assess whether recombinant 118L protein can induce membrane fusion when added to target cells, using lipid mixing or content mixing assays.
Immunofluorescence and electron microscopy: Track the localization of 118L during viral entry and replication using specific antibodies coupled with appropriate microscopy techniques.
Complementation assays: Attempt to rescue 118L-deficient viral particles by providing the 118L protein in trans through a separate expression vector.
Creating viable IIV6-118L knockout mutants presents significant challenges, illuminated by previous research attempts:
Essential nature of the protein: Attempts to isolate mutant viruses with the 118L gene deletion have been unsuccessful, suggesting the protein is essential for virus replication . Specifically, researchers were able to identify virus mutants in which the 118L gene sequence had been replaced with gfp by fluorescence microscopy, but these mutants could not be propagated separately from the wild-type virus in insect cells .
Technical approaches to overcome this limitation:
Conditional knockout systems, where 118L expression can be regulated
Trans-complementation approaches, providing 118L expression from helper constructs
CRISPR/Cas9-based approaches with inducible systems
Temperature-sensitive mutants that function at permissive temperatures
Alternative strategies: Since complete knockouts may not be viable, researchers can:
Create partial deletions or point mutations to identify critical domains
Use dominant-negative approaches by expressing modified versions of 118L
Employ temporally controlled silencing using inducible RNAi systems
Protein-protein interaction studies have revealed important insights about 118L's role in virion structure:
Interaction with 415R protein: The 415R protein of IIV6 interacts reciprocally with both 118L (envelope protein) and 274L (major capsid protein), suggesting 415R functions as a matrix protein that bridges the capsid and envelope components . This interaction was demonstrated using yeast two-hybrid system analysis.
Virion structural organization: The positioning of 118L in the envelope and its interaction with the putative matrix protein 415R suggests a structured assembly process where:
The major capsid protein (274L) forms the icosahedral capsid
The matrix protein (415R) interacts with both capsid and envelope components
The envelope protein (118L) is incorporated into the viral membrane
Research approaches to study these interactions:
Co-immunoprecipitation assays to confirm interactions in infected cells
Proximity ligation assays to visualize protein-protein interactions in situ
Cross-linking experiments followed by mass spectrometry to map interaction interfaces
Cryo-electron microscopy to visualize the structural arrangement of these proteins in intact virions
Understanding these interactions is crucial for developing a comprehensive model of IIV6 virion assembly and potential targets for antiviral intervention.
Antibodies against 118L have shown virus-neutralizing capabilities, suggesting promising avenues for research:
Generation of neutralizing antibodies:
Neutralization assay methodologies:
Plaque reduction neutralization tests: Quantify reduction in viral plaques when virus is pre-incubated with anti-118L antibodies
Yield reduction assays: Measure viral titers in infected cultures treated with antibodies
Immunofluorescence-based entry inhibition assays: Visualize reduced viral entry in presence of antibodies
Epitope mapping techniques:
Peptide scanning to identify linear epitopes recognized by neutralizing antibodies
Mutational analysis to identify critical residues for antibody binding
Competition assays with defined antibodies to characterize epitope relationships
Mechanism-of-action studies:
Pre- vs. post-attachment neutralization assays to determine which stage of entry is blocked
Fusion inhibition assays to assess if antibodies block membrane fusion
Single-particle tracking to visualize how antibodies interfere with virion behavior during entry
These approaches can provide valuable insights into both the function of 118L and potential antiviral strategies targeting this essential protein.
Given 118L's essential role in viral replication, it represents a promising target for antiviral development:
High-throughput screening approaches:
Develop cell-based assays that measure IIV6 replication in the presence of candidate compounds
Use recombinant IIV6 expressing reporter genes (such as GFP) to facilitate rapid screening
Implement biochemical assays with purified 118L to identify direct-binding compounds
Structure-based drug design:
Determine the three-dimensional structure of 118L using X-ray crystallography or cryo-EM
Identify potential binding pockets for small molecule inhibitors
Employ in silico docking studies to screen virtual compound libraries
Peptide-based inhibitors:
Design peptides that mimic interaction domains between 118L and other viral proteins
Test peptides derived from the 415R interaction interface with 118L
Develop cell-penetrating peptides targeting intracellular assembly steps
Validation approaches:
Demonstrate specific targeting of 118L through resistance mutations mapping to the 118L gene
Show correlation between 118L binding and antiviral activity
Conduct combination studies with inhibitors targeting different viral functions
The goal of these approaches would be to develop inhibitors that specifically block the function of 118L, potentially serving as tools for further understanding 118L biology and as leads for antiviral development.
The 118L ORF is highly conserved across iridoviruses, providing important evolutionary insights:
Conservation pattern:
Functional implications:
Essential proteins typically show higher conservation due to functional constraints
The conservation of predicted transmembrane domains and modification sites suggests these features are critical for function
Research approaches to leverage conservation:
Comparative genomics analysis to identify absolutely conserved residues as candidates for functional studies
Complementation assays testing whether orthologs from related viruses can substitute for IIV6-118L
Phylogenetic analysis to trace the evolution of 118L in relation to host range and virulence
Identification of functional motifs:
Alignment of 118L sequences from different iridoviruses to identify conserved motifs
Correlation of sequence variations with differences in host range or tissue tropism
Prediction of conserved structural elements that could be targeted by broad-spectrum antivirals
Research on IIV6-118L has implications for understanding vertebrate iridoviruses, which are important pathogens of fish, amphibians, and reptiles:
Translational aspects:
Cross-species infection potential:
Comparative structural biology:
Structural studies of 118L could inform models of homologous proteins in vertebrate iridoviruses
Conservation of protein-protein interactions, such as those between 118L and 415R, may reveal fundamental aspects of iridovirus architecture
Evolutionary adaptation studies:
Comparison of 118L from insect iridoviruses with homologs from vertebrate iridoviruses could reveal adaptive changes associated with host switching
Identification of key mutations that facilitate adaptation to different host cell types
This comparative approach highlights the value of IIV6-118L research beyond invertebrate virology, with potential applications to understanding and controlling iridovirus infections in vertebrate hosts.
For successful expression and purification of recombinant IIV6-118L, researchers should consider the following protocols and optimizations:
Expression systems:
E. coli: His-tagged versions have been successfully produced , though membrane proteins often require specialized strains and conditions
Baculovirus expression system: Successfully used for generating immunogenic 118L protein , offering proper folding and post-translational modifications
Cell-free systems: May be considered for initial screening of expression conditions
Expression optimization strategies:
Lower induction temperatures (16-25°C) to facilitate proper folding
Use of fusion tags known to enhance membrane protein solubility (MBP, SUMO)
Codon optimization for the expression host
Inclusion of appropriate detergents during extraction
Purification approaches:
Two-step purification using affinity chromatography followed by size exclusion
Detergent screening to identify optimal conditions for extraction while maintaining native structure
Consideration of lipid nanodisc or amphipol systems for maintaining membrane protein structure
Quality control methods:
Circular dichroism to assess secondary structure
Dynamic light scattering to verify monodispersity
Functional assays such as liposome binding to verify activity
Success in recombinant expression will facilitate structural studies and enable the development of biochemical assays to further characterize 118L function and interactions.
Understanding the membrane topology of 118L is crucial for elucidating its function. Several complementary approaches can be employed:
Computational prediction:
Use of multiple prediction algorithms to identify transmembrane domains
Signal peptide and topology prediction tools
Hydrophobicity analysis and conservation mapping
Biochemical approaches:
Protease protection assays: Differential digestion of domains on either side of the membrane
Glycosylation mapping: Introduction of artificial glycosylation sites to determine lumenal domains
Cysteine accessibility methods: Chemical modification of exposed cysteine residues
Fluorescence-based methods:
GFP-fusion analysis: Fluorescence patterns indicating cytoplasmic or lumenal localization of protein termini
FRET analysis with known topology markers
pH-sensitive fluorescent proteins to distinguish between cellular compartments
Structural biology approaches:
Cryo-electron microscopy of 118L in vitrified membranes
NMR studies of specific domains
X-ray crystallography of purified protein in detergent micelles or lipidic cubic phase
These approaches can generate a comprehensive model of how 118L is oriented and integrated into the viral envelope, informing hypotheses about its role in viral entry and assembly.